IDARUCIZUMAB

IDARUCIZUMAB was reported 1321 times

IDARUCIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIMB GIRTH INCREASED 1 0.1250
1 COAGULATION FACTOR INCREASED 5 0.0926
2 THROMBIN TIME ABNORMAL 3 0.0714
3 DECOMPRESSIVE CRANIECTOMY 1 0.0667
4 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0428
5 PROCEDURAL SHOCK 1 0.0385
6 BASILAR ARTERY ANEURYSM 1 0.0370
7 BASILAR ARTERY OCCLUSION 5 0.0362
8 BASAL GANGLIA HAEMATOMA 1 0.0323
9 SPLEEN SCAN ABNORMAL 1 0.0323
10 THROMBIN TIME PROLONGED 6 0.0288
11 URACHAL ABNORMALITY 1 0.0250
12 ANTICOAGULATION DRUG LEVEL ABNORMAL 2 0.0233
13 CEREBRAL DYSGENESIS 1 0.0222
14 POSTOPERATIVE RESPIRATORY FAILURE 2 0.0222
15 CORONARY BYPASS THROMBOSIS 1 0.0213
16 QUADRANTANOPIA 2 0.0202
17 HAEMORRHAGIC TRANSFORMATION STROKE 26 0.0199
18 HAEMORRHAGE CORONARY ARTERY 1 0.0179
19 BROWN-SEQUARD SYNDROME 1 0.0169
20 VERTEBRAL ARTERY OCCLUSION 3 0.0162
21 HAEMORRHAGIC CHOLECYSTITIS 1 0.0154
22 MESENTERIC HAEMORRHAGE 1 0.0149
23 HYPERALBUMINAEMIA 1 0.0143
24 NIH STROKE SCALE SCORE INCREASED 1 0.0137
25 COLONIC HAEMATOMA 1 0.0132
26 POST PROCEDURAL URINE LEAK 1 0.0119
27 RECTAL PERFORATION 5 0.0114
28 SCROTAL HAEMATOMA 1 0.0112
29 STROKE IN EVOLUTION 2 0.0111
30 GENITAL NEOPLASM MALIGNANT FEMALE 1 0.0105
31 BASAL GANGLIA STROKE 1 0.0096
32 SUBCAPSULAR RENAL HAEMATOMA 1 0.0094
33 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 2 0.0093
34 TRAUMATIC HAEMOTHORAX 2 0.0092
35 SPINAL SUBDURAL HAEMATOMA 1 0.0091
36 LACUNAR STROKE 2 0.0090
37 COAGULATION TIME PROLONGED 12 0.0088
38 SUBARACHNOID HAEMATOMA 1 0.0087
39 POST PROCEDURAL PNEUMONIA 2 0.0087
40 BRONCHIAL NEOPLASM 1 0.0084
41 SPINDLE CELL SARCOMA 1 0.0082
42 HAEMOSTASIS 1 0.0080
43 PROSTATIC OBSTRUCTION 1 0.0070
44 INTESTINAL STRANGULATION 1 0.0070
45 VASCULAR PROCEDURE COMPLICATION 1 0.0069
46 CONJUNCTIVAL PALLOR 1 0.0066
47 NEUROSURGERY 1 0.0065
48 HAEMORRHAGIC CEREBRAL INFARCTION 4 0.0062
49 HEPATIC RUPTURE 1 0.0057
50 GASTROINTESTINAL LYMPHOMA 1 0.0057
51 EYE HAEMATOMA 1 0.0055
52 COMPLICATIONS OF TRANSPLANTED HEART 1 0.0055
53 RENAL NECROSIS 1 0.0054
54 HAEMORRHAGIC DISORDER 5 0.0054
55 ANEURYSM RUPTURED 4 0.0053
56 SHOCK HAEMORRHAGIC 32 0.0051
57 HAEMORRHAGE INTRACRANIAL 66 0.0050
58 RESPIRATORY FATIGUE 1 0.0049
59 PANCREATIC INJURY 1 0.0048
60 BRAIN CONTUSION 3 0.0047
61 PERICARDIAL HAEMORRHAGE 9 0.0047
62 AORTIC ANEURYSM RUPTURE 4 0.0047
63 CEREBRAL ARTERY THROMBOSIS 2 0.0045
64 PACKAGING DESIGN ISSUE 1 0.0044
65 VESSEL PUNCTURE SITE HAEMORRHAGE 1 0.0044
66 PRODUCT APPEARANCE CONFUSION 3 0.0043
67 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0042
68 VASCULAR ENCEPHALOPATHY 1 0.0042
69 HAEMORRHAGIC INFARCTION 2 0.0041
70 PROCOAGULANT THERAPY 3 0.0040
71 GALLBLADDER RUPTURE 1 0.0040
72 PNEUMONIA ESCHERICHIA 1 0.0040
73 CEREBELLAR HAEMATOMA 1 0.0038
74 MYOCARDIAL RUPTURE 1 0.0038
75 BLEEDING TIME PROLONGED 4 0.0037
76 POST PROCEDURAL BILE LEAK 1 0.0036
77 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0036
78 PROCEDURAL HAEMORRHAGE 10 0.0035
79 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0035
80 LOW CARDIAC OUTPUT SYNDROME 1 0.0034
81 NEUROLOGICAL DECOMPENSATION 6 0.0034
82 COAGULATION TIME SHORTENED 1 0.0033
83 ARTERIAL HAEMORRHAGE 3 0.0033
84 CAROTID ARTERY THROMBOSIS 2 0.0033
85 METASTATIC CARCINOMA OF THE BLADDER 1 0.0033
86 VIRAL RASH 1 0.0032
87 COAGULATION TEST ABNORMAL 2 0.0032
88 FEMORAL ARTERY OCCLUSION 1 0.0032
89 HYPOVOLAEMIC SHOCK 12 0.0031
90 SOFT TISSUE HAEMORRHAGE 1 0.0031
91 MUCOSAL HAEMORRHAGE 3 0.0031
92 CRANIOTOMY 1 0.0030
93 MULTIPLE ORGAN DYSFUNCTION SYNDROME 58 0.0030
94 AORTIC DISSECTION 11 0.0030
95 VASCULAR STENT OCCLUSION 1 0.0030
96 MULTIMORBIDITY 3 0.0029
97 CORTISOL INCREASED 1 0.0029
98 CEREBRAL HAEMATOMA 8 0.0028
99 CAROTID ARTERY DISSECTION 1 0.0028
100 ISCHAEMIC STROKE 42 0.0028
101 LEFT ATRIAL ENLARGEMENT 1 0.0028
102 NEUROGENIC SHOCK 1 0.0028
103 INTRACRANIAL MASS 2 0.0027
104 PELVIC HAEMATOMA 1 0.0027
105 FACIAL NERVE DISORDER 1 0.0026
106 BILIARY SEPSIS 1 0.0026
107 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0026
108 SUBDURAL HAEMORRHAGE 6 0.0025
109 PANCREATITIS HAEMORRHAGIC 1 0.0025
110 CEREBRAL HAEMORRHAGE 75 0.0025
111 TRAUMATIC HAEMORRHAGE 3 0.0025
112 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0024
113 CARDIAC VALVE VEGETATION 1 0.0023
114 QUADRIPARESIS 3 0.0023
115 INTRAVENTRICULAR HAEMORRHAGE 5 0.0023
116 SPINAL EPIDURAL HAEMATOMA 1 0.0022
117 CEREBRAL ARTERY OCCLUSION 2 0.0022
118 POSTOPERATIVE ILEUS 1 0.0022
119 INTRACRANIAL HAEMATOMA 1 0.0021
120 METASTASES TO PELVIS 1 0.0021
121 RECTAL ULCER 2 0.0021
122 POST PROCEDURAL SEPSIS 1 0.0020
123 URETHRAL HAEMORRHAGE 1 0.0020
124 SUPERIOR VENA CAVA SYNDROME 1 0.0020
125 CARDIOGENIC SHOCK 21 0.0020
126 COAGULOPATHY 28 0.0020
127 MONOPARESIS 3 0.0020
128 ILEUS PARALYTIC 7 0.0020
129 PUPILLARY DISORDER 1 0.0019
130 THALAMIC INFARCTION 1 0.0019
131 REBOUND EFFECT 13 0.0019
132 RESPIRATORY TRACT HAEMORRHAGE 1 0.0019
133 BRAIN MIDLINE SHIFT 1 0.0019
134 DISEASE COMPLICATION 7 0.0018
135 PULMONARY SEPSIS 2 0.0018
136 PERITONEAL DISORDER 1 0.0018
137 RUPTURED CEREBRAL ANEURYSM 1 0.0018
138 PERFORATION 1 0.0018
139 CARDIOPULMONARY FAILURE 6 0.0018
140 ISCHAEMIA 7 0.0017
141 BILIARY OBSTRUCTION 1 0.0017
142 EXTRADURAL HAEMATOMA 2 0.0017
143 POST PROCEDURAL HAEMORRHAGE 17 0.0017
144 PUNCTURE SITE HAEMORRHAGE 1 0.0017
145 INTESTINAL HAEMORRHAGE 8 0.0017
146 BRAIN HERNIATION 4 0.0016
147 BRAIN STEM SYNDROME 1 0.0016
148 DISCOLOURED VOMIT 1 0.0016
149 VITAL FUNCTIONS ABNORMAL 1 0.0016
150 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0016
151 HEMIANOPIA HOMONYMOUS 1 0.0016
152 CARDIAC TAMPONADE 6 0.0015
153 HAPTOGLOBIN DECREASED 1 0.0015
154 THROMBOTIC STROKE 1 0.0015
155 ABDOMINAL SEPSIS 1 0.0015
156 PRODUCT LABEL CONFUSION 6 0.0015
157 DEVICE RELATED THROMBOSIS 1 0.0014
158 BASAL GANGLIA HAEMORRHAGE 1 0.0014
159 ENTEROCOCCAL SEPSIS 1 0.0014
160 CARDIOVASCULAR INSUFFICIENCY 2 0.0014
161 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0014
162 CREATININE RENAL CLEARANCE DECREASED 5 0.0014
163 SIMPLE PARTIAL SEIZURES 1 0.0014
164 BRAIN OEDEMA 14 0.0014
165 HAEMORRHAGIC STROKE 9 0.0013
166 INTESTINAL ISCHAEMIA 6 0.0013
167 CARDIAC OUTPUT DECREASED 1 0.0013
168 ADENOCARCINOMA OF COLON 2 0.0013
169 HYPOFIBRINOGENAEMIA 1 0.0013
170 VASOSPASM 1 0.0013
171 CEREBRAL INFARCTION 27 0.0013
172 THALAMUS HAEMORRHAGE 1 0.0013
173 CEREBRAL ISCHAEMIA 6 0.0013
174 MICROANGIOPATHY 1 0.0013
175 CAROTID ARTERY STENOSIS 4 0.0013
176 SUBARACHNOID HAEMORRHAGE 11 0.0013
177 SHOCK 23 0.0013
178 GASTROINTESTINAL NECROSIS 3 0.0012
179 HAEMOTHORAX 3 0.0012
180 PULSELESS ELECTRICAL ACTIVITY 4 0.0012
181 HAEMORRHAGE 101 0.0012
182 BLOOD URINE 1 0.0012
183 BLADDER CANCER RECURRENT 1 0.0012
184 INTESTINAL INFARCTION 1 0.0012
185 SMALL INTESTINAL HAEMORRHAGE 2 0.0012
186 PNEUMONIA STREPTOCOCCAL 1 0.0012
187 PRODUCT NAME CONFUSION 1 0.0011
188 RENAL HAEMORRHAGE 2 0.0011
189 TINEA INFECTION 1 0.0011
190 AORTIC THROMBOSIS 1 0.0011
191 HEMIPARESIS 16 0.0011
192 PRODUCT MEASURED POTENCY ISSUE 1 0.0011
193 PELVIC ABSCESS 1 0.0011
194 BRAIN STEM INFARCTION 1 0.0011
195 SUBDURAL HAEMATOMA 13 0.0011
196 NOSOCOMIAL INFECTION 2 0.0010
197 GASTROINTESTINAL HAEMORRHAGE 77 0.0010
198 VASCULAR CALCIFICATION 1 0.0010
199 CATHETER SITE HAEMORRHAGE 2 0.0010
200 MELAENA 19 0.0010
201 EMBOLIC STROKE 3 0.0010
202 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
203 CARDIAC DEATH 1 0.0009
204 PERIPHERAL EMBOLISM 1 0.0009
205 SEPTIC SHOCK 31 0.0009
206 PROTHROMBIN TIME PROLONGED 5 0.0009
207 SUBCUTANEOUS HAEMATOMA 1 0.0009
208 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0009
209 PERIPHERAL ARTERY THROMBOSIS 1 0.0009
210 HAEMATOMA 20 0.0009
211 INTRACRANIAL PRESSURE INCREASED 4 0.0009
212 CHOLANGIOCARCINOMA 1 0.0009
213 HAEMODYNAMIC INSTABILITY 5 0.0009
214 PRERENAL FAILURE 1 0.0009
215 MYELITIS 1 0.0009
216 CRANIOCEREBRAL INJURY 2 0.0009
217 HYPERTROPHIC CARDIOMYOPATHY 1 0.0008
218 STENOSIS 1 0.0008
219 ACUTE CORONARY SYNDROME 6 0.0008
220 ANAEMIA POSTOPERATIVE 1 0.0008
221 CEREBELLAR HAEMORRHAGE 1 0.0008
222 LIVER ABSCESS 2 0.0008
223 MEGACOLON 1 0.0008
224 APHASIA 20 0.0008
225 DUODENAL ULCER HAEMORRHAGE 2 0.0008
226 BLOOD CREATININE ABNORMAL 2 0.0008
227 GASTRITIS HAEMORRHAGIC 1 0.0008
228 CARDIAC ABLATION 1 0.0007
229 BRAIN INJURY 6 0.0007
230 PNEUMONIA KLEBSIELLA 1 0.0007
231 RESUSCITATION 1 0.0007
232 SPLENIC INFARCTION 1 0.0007
233 GAZE PALSY 1 0.0007
234 CEREBELLAR INFARCTION 1 0.0007
235 INTESTINAL POLYP 1 0.0007
236 BLOOD LOSS ANAEMIA 1 0.0007
237 UROSEPSIS 5 0.0007
238 PNEUMOPERITONEUM 1 0.0007
239 HEPATORENAL SYNDROME 1 0.0007
240 AORTIC VALVE STENOSIS 1 0.0007
241 ANURIA 5 0.0007
242 HAEMORRHAGIC DIATHESIS 2 0.0007
243 PUPIL FIXED 1 0.0007
244 CEREBRAL VENOUS THROMBOSIS 1 0.0007
245 PERITONITIS 11 0.0006
246 TRAUMATIC LUNG INJURY 1 0.0006
247 HYPOVOLAEMIA 3 0.0006
248 TONGUE OEDEMA 2 0.0006
249 CHEST INJURY 1 0.0006
250 CIRCULATORY COLLAPSE 9 0.0006
251 HAEMATEMESIS 13 0.0006
252 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0006
253 HYPERCOAGULATION 1 0.0006
254 ARTERIAL THROMBOSIS 1 0.0006
255 ABDOMINAL WALL HAEMATOMA 1 0.0006
256 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0006
257 METASTATIC NEOPLASM 2 0.0006
258 ANAPHYLACTOID REACTION 2 0.0006
259 VOLVULUS 1 0.0006
260 URINARY BLADDER HAEMORRHAGE 1 0.0006
261 EMBOLISM 4 0.0006
262 HEMIPLEGIA 4 0.0006
263 ENDOMETRIAL CANCER 1 0.0006
264 LARGE INTESTINAL HAEMORRHAGE 1 0.0006
265 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0006
266 COLITIS ISCHAEMIC 3 0.0005
267 VENOUS THROMBOSIS LIMB 1 0.0005
268 CALCINOSIS 1 0.0005
269 RETROPERITONEAL HAEMATOMA 1 0.0005
270 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0005
271 HAEMATURIA 15 0.0005
272 PNEUMONIA ASPIRATION 10 0.0005
273 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
274 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0005
275 MULTIPLE INJURIES 3 0.0005
276 PROCTITIS 1 0.0005
277 RIGHT VENTRICULAR FAILURE 3 0.0005
278 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0005
279 HAEMORRHAGE URINARY TRACT 1 0.0005
280 ASPIRATION 4 0.0005
281 ACIDOSIS 3 0.0005
282 HYPERVOLAEMIA 1 0.0005
283 NEUTROPHIL COUNT ABNORMAL 1 0.0005
284 ENDOTRACHEAL INTUBATION 1 0.0005
285 LARGE INTESTINAL ULCER 1 0.0005
286 SEPSIS 42 0.0005
287 CHOLECYSTITIS INFECTIVE 1 0.0005
288 ANAL HAEMORRHAGE 1 0.0004
289 PULMONARY HAEMORRHAGE 3 0.0004
290 CARDIAC FAILURE 29 0.0004
291 RECTAL HAEMORRHAGE 16 0.0004
292 DRUG EFFECT DELAYED 2 0.0004
293 PROCEDURAL COMPLICATION 3 0.0004
294 VENTRICULAR HYPERTROPHY 1 0.0004
295 ACUTE MYOCARDIAL INFARCTION 11 0.0004
296 CLUMSINESS 1 0.0004
297 INTERNAL HAEMORRHAGE 4 0.0004
298 CEREBRAL THROMBOSIS 1 0.0004
299 CARDIAC ARREST 29 0.0004
300 PARAPLEGIA 1 0.0004
301 CUSHINGOID 1 0.0004
302 CARDIAC FAILURE ACUTE 2 0.0004
303 RECTAL CANCER 1 0.0004
304 LARYNGEAL OEDEMA 2 0.0004
305 BRAIN DEATH 1 0.0004
306 GINGIVAL BLEEDING 4 0.0004
307 COMA 15 0.0004
308 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0004
309 ACUTE KIDNEY INJURY 43 0.0004
310 VENTRICULAR HYPOKINESIA 1 0.0004
311 HEPATIC CYST 1 0.0004
312 CEREBRAL DISORDER 2 0.0004
313 HYPERPYREXIA 1 0.0004
314 PEPTIC ULCER 1 0.0004
315 LARGE INTESTINE PERFORATION 2 0.0003
316 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0003
317 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
318 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
319 AORTIC STENOSIS 1 0.0003
320 B-CELL LYMPHOMA 1 0.0003
321 ACUTE RESPIRATORY FAILURE 5 0.0003
322 LACTIC ACIDOSIS 8 0.0003
323 INTRACARDIAC THROMBUS 1 0.0003
324 INCORRECT DRUG ADMINISTRATION RATE 1 0.0003
325 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0003
326 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
327 WOUND HAEMORRHAGE 1 0.0003
328 AZOTAEMIA 1 0.0003
329 CAROTID ARTERY OCCLUSION 1 0.0003
330 SUDDEN CARDIAC DEATH 1 0.0003
331 TRANSPLANT REJECTION 2 0.0003
332 SKIN HAEMORRHAGE 3 0.0003
333 RESPIRATORY FAILURE 19 0.0003
334 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
335 POST PROCEDURAL COMPLICATION 5 0.0003
336 PRODUCT ADMINISTRATION ERROR 4 0.0003
337 SPINAL CORD COMPRESSION 1 0.0003
338 BLOOD DISORDER 2 0.0003
339 AORTIC ANEURYSM 2 0.0003
340 CARDIO-RESPIRATORY ARREST 11 0.0003
341 CARDIAC FAILURE CHRONIC 1 0.0003
342 ARTHRITIS BACTERIAL 1 0.0003
343 DIVERTICULUM INTESTINAL 1 0.0003
344 PRODUCT PREPARATION ISSUE 1 0.0003
345 CERVIX CARCINOMA 1 0.0003
346 ABDOMINAL ABSCESS 1 0.0003
347 ORGAN FAILURE 1 0.0003
348 LIP OEDEMA 1 0.0003
349 TACHYPNOEA 3 0.0003
350 EXTRAVASATION 1 0.0003
351 LEFT VENTRICULAR HYPERTROPHY 1 0.0003
352 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0003
353 ENTEROCOCCAL INFECTION 1 0.0003
354 GUILLAIN-BARRE SYNDROME 1 0.0003
355 MEDICATION ERROR 12 0.0003
356 LUNG INFECTION 4 0.0003
357 RENAL TUBULAR NECROSIS 2 0.0003
358 BRAIN NEOPLASM MALIGNANT 1 0.0002
359 HYPERNATRAEMIA 1 0.0002
360 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
361 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
362 RENAL FAILURE 29 0.0002
363 GASTRITIS EROSIVE 1 0.0002
364 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
365 ANEURYSM 1 0.0002
366 ABDOMINAL TENDERNESS 1 0.0002
367 HAEMATOCHEZIA 10 0.0002
368 DEATH 159 0.0002
369 HAEMORRHAGIC ANAEMIA 1 0.0002
370 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
371 CHOLANGITIS 1 0.0002
372 PERICARDIAL EFFUSION 4 0.0002
373 PRODUCT DISPENSING ERROR 3 0.0002
374 HAEMOPTYSIS 5 0.0002
375 NECROSIS 1 0.0002
376 CHOLECYSTITIS ACUTE 1 0.0002
377 EPISTAXIS 13 0.0002
378 ILEUS 2 0.0002
379 HAEMOGLOBIN ABNORMAL 1 0.0002
380 RESPIRATORY TRACT INFECTION 4 0.0002
381 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
382 BLOOD PRESSURE ABNORMAL 3 0.0002
383 CEREBROVASCULAR ACCIDENT 29 0.0002
384 HAEMOGLOBIN DECREASED 17 0.0002
385 HEPATIC FAILURE 5 0.0002
386 HERPES SIMPLEX 1 0.0002
387 GASTRIC HAEMORRHAGE 2 0.0002
388 PULMONARY EMBOLISM 16 0.0002
389 MYOCARDIAL ISCHAEMIA 2 0.0002
390 INFUSION SITE EXTRAVASATION 1 0.0002
391 POSTOPERATIVE WOUND INFECTION 1 0.0002
392 EXPIRED PRODUCT ADMINISTERED 5 0.0002
393 BEDRIDDEN 2 0.0002
394 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
395 ALTERED STATE OF CONSCIOUSNESS 3 0.0002
396 TROPONIN INCREASED 1 0.0002
397 ULCER HAEMORRHAGE 1 0.0002
398 CARDIOMEGALY 2 0.0002
399 BLINDNESS UNILATERAL 2 0.0002
400 DUODENAL ULCER 1 0.0002
401 ECCHYMOSIS 1 0.0002
402 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0002
403 HYPOTENSION 27 0.0002
404 CORONARY ARTERY OCCLUSION 2 0.0002
405 PRODUCT CONTAINER ISSUE 1 0.0002
406 CARDIOMYOPATHY 2 0.0002
407 TRICUSPID VALVE INCOMPETENCE 1 0.0002
408 INFARCTION 1 0.0002
409 ESCHERICHIA INFECTION 1 0.0002
410 PELVIC FRACTURE 1 0.0002
411 PNEUMOTHORAX 2 0.0002
412 EJECTION FRACTION DECREASED 2 0.0002
413 PNEUMONIA 40 0.0002
414 HAEMOLYSIS 1 0.0002
415 HAEMARTHROSIS 1 0.0002
416 FACIAL PARALYSIS 1 0.0002
417 ASPHYXIA 1 0.0002
418 PNEUMONIA BACTERIAL 1 0.0002
419 URINARY RETENTION 4 0.0001
420 DIVERTICULUM 1 0.0001
421 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
422 SKIN PLAQUE 1 0.0001
423 DELIRIUM 4 0.0001
424 NERVOUS SYSTEM DISORDER 4 0.0001
425 SURGERY 6 0.0001
426 PRODUCT PACKAGING ISSUE 1 0.0001
427 HEPATIC FUNCTION ABNORMAL 4 0.0001
428 ANAEMIA 22 0.0001
429 HEPATIC CIRRHOSIS 2 0.0001
430 RENAL IMPAIRMENT 9 0.0001
431 URINE OUTPUT DECREASED 1 0.0001
432 BLOOD BILIRUBIN INCREASED 3 0.0001
433 DRUG ADMINISTRATION ERROR 4 0.0001
434 EPILEPSY 3 0.0001
435 DRUG LEVEL DECREASED 1 0.0001
436 OVARIAN CANCER 1 0.0001
437 PRODUCT PRESCRIBING ERROR 2 0.0001
438 SINUS BRADYCARDIA 1 0.0001
439 RESPIRATORY DISORDER 3 0.0001
440 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
441 METABOLIC ACIDOSIS 3 0.0001
442 END STAGE RENAL DISEASE 2 0.0001
443 RESPIRATORY ARREST 3 0.0001
444 LARYNGITIS 1 0.0001
445 AFFECT LABILITY 1 0.0001
446 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
447 GASTROINTESTINAL CARCINOMA 1 0.0001
448 PETECHIAE 1 0.0001
449 MALNUTRITION 1 0.0001
450 DRUG INTERACTION 15 0.0001
451 OESOPHAGITIS 1 0.0001
452 PRODUCT USE COMPLAINT 1 0.0001
453 INTESTINAL PERFORATION 1 0.0001
454 LUNG NEOPLASM MALIGNANT 4 0.0001
455 DEVICE OCCLUSION 1 0.0001
456 PULMONARY OEDEMA 4 0.0001
457 MITRAL VALVE INCOMPETENCE 1 0.0001
458 DEEP VEIN THROMBOSIS 6 0.0001
459 GENERALISED OEDEMA 1 0.0001
460 DYSARTHRIA 3 0.0001
461 MYDRIASIS 1 0.0001
462 SARS-COV-2 TEST POSITIVE 1 0.0001
463 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
464 BLOOD PRESSURE DECREASED 5 0.0001
465 INFECTION 10 0.0001
466 THROMBOSIS 6 0.0001
467 ROAD TRAFFIC ACCIDENT 3 0.0001
468 RESPIRATORY DISTRESS 2 0.0001
469 CARDIOVASCULAR DISORDER 2 0.0001
470 INJECTION SITE EXTRAVASATION 1 0.0001
471 JAUNDICE 2 0.0001
472 SOPOR 1 0.0001
473 PARALYSIS 1 0.0001
474 MYELODYSPLASTIC SYNDROME 1 0.0001
475 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
476 METASTASES TO BONE 1 0.0001
477 LYMPHOMA 1 0.0001
478 CYANOSIS 1 0.0001
479 ATRIAL FIBRILLATION 6 0.0001
480 DRUG LEVEL INCREASED 1 0.0001
481 VENTRICULAR TACHYCARDIA 1 0.0001
482 BLOOD CREATININE INCREASED 4 0.0001
483 EOSINOPHILIA 1 0.0001
484 CORONARY ARTERY DISEASE 2 0.0001
485 HYPERKALAEMIA 2 0.0001
486 SENSORY DISTURBANCE 1 0.0001
487 INTESTINAL OBSTRUCTION 2 0.0001
488 PROTEINURIA 1 0.0001
489 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
490 MYOCARDIAL INFARCTION 11 0.0001
491 TACHYCARDIA 5 0.0001
492 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
493 SPEECH DISORDER 3 0.0001
494 COLD SWEAT 1 0.0001
495 DRUG DISPENSING ERROR 1 0.0001
496 KIDNEY INFECTION 1 0.0001
497 DEHYDRATION 7 0.0001
498 BLOOD URINE PRESENT 1 0.0001
499 HAEMORRHOIDS 1 0.0001
500 RIB FRACTURE 1 0.0001
501 PLEURAL EFFUSION 3 0.0001
502 METRORRHAGIA 1 0.0001
503 CONDITION AGGRAVATED 13 0.0001
504 HAEMATOCRIT DECREASED 1 0.0001
505 OVERDOSE 10 0.0001
506 ANGIOEDEMA 2 0.0001
507 DRUG EFFECT DECREASED 3 0.0001
508 DRUG INEFFECTIVE 59 0.0001
509 DRUG EFFECT INCOMPLETE 2 0.0001
510 TRANSAMINASES INCREASED 1 0.0001
511 ABDOMINAL PAIN 10 0.0001
512 TOOTH DISORDER 1 0.0001
513 RENAL DISORDER 2 0.0001
514 ENCEPHALOPATHY 1 0.0001
515 ANAPHYLACTIC SHOCK 1 0.0001
516 DRUG RESISTANCE 1 0.0001
517 PNEUMONITIS 1 0.0000
518 TREATMENT FAILURE 3 0.0000
519 ANAPHYLACTIC REACTION 2 0.0000
520 INJURY 3 0.0000
521 OXYGEN SATURATION DECREASED 2 0.0000
522 PROCEDURAL PAIN 1 0.0000
523 SKIN LESION 1 0.0000
524 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
525 GASTRITIS 1 0.0000
526 THROMBOCYTOPENIA 4 0.0000
527 BRADYCARDIA 2 0.0000
528 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
529 PALLOR 1 0.0000
530 RED BLOOD CELL COUNT DECREASED 1 0.0000
531 EXTRA DOSE ADMINISTERED 1 0.0000
532 THERAPEUTIC RESPONSE DECREASED 2 0.0000
533 PRODUCT STORAGE ERROR 2 0.0000
534 GASTRIC CANCER 1 0.0000
535 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
536 INTENTIONAL OVERDOSE 2 0.0000
537 DYSSTASIA 1 0.0000
538 FALL 11 0.0000
539 BLOOD POTASSIUM DECREASED 1 0.0000
540 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
541 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
542 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
543 CONTUSION 3 0.0000
544 CHEST PAIN 6 0.0000
545 TOXICITY TO VARIOUS AGENTS 5 0.0000
546 PANCREATIC CARCINOMA 1 0.0000
547 ABDOMINAL DISCOMFORT 5 0.0000
548 LOSS OF CONSCIOUSNESS 4 0.0000
549 MOVEMENT DISORDER 1 0.0000
550 FEMUR FRACTURE 1 0.0000
551 LIP SWELLING 1 0.0000
552 HYPOXIA 1 0.0000
553 COLITIS 1 0.0000
554 STAPHYLOCOCCAL INFECTION 1 0.0000
555 BONE DENSITY DECREASED 1 0.0000
556 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
557 HEART RATE DECREASED 1 0.0000
558 RESTLESSNESS 1 0.0000
559 MUSCULAR WEAKNESS 3 0.0000
560 VOMITING 12 0.0000
561 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
562 UNEVALUABLE EVENT 2 0.0000
563 URINARY TRACT INFECTION 4 0.0000
564 DYSKINESIA 1 0.0000
565 RHABDOMYOLYSIS 1 0.0000
566 HYPERTENSION 5 0.0000
567 DISORIENTATION 1 0.0000
568 CHRONIC KIDNEY DISEASE 2 0.0000
569 LIVER DISORDER 1 0.0000
570 ABNORMAL BEHAVIOUR 1 0.0000
571 MENTAL DISORDER 1 0.0000
572 NEPHROLITHIASIS 1 0.0000
573 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
574 HYPOKALAEMIA 1 0.0000
575 DYSPHAGIA 2 0.0000
576 VAGINAL HAEMORRHAGE 1 0.0000
577 HYPERSENSITIVITY 4 0.0000
578 LUNG DISORDER 1 0.0000
579 ARRHYTHMIA 1 0.0000
580 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
581 HYPOGLYCAEMIA 1 0.0000
582 COVID-19 3 0.0000
583 BLOOD PRESSURE INCREASED 3 0.0000
584 OEDEMA 1 0.0000
585 PANCREATITIS 1 0.0000
586 WHEEZING 1 0.0000
587 NERVOUSNESS 1 0.0000
588 HERPES ZOSTER 1 0.0000
589 OFF LABEL USE 12 0.0000
590 PYREXIA 5 0.0000
591 DYSPNOEA 8 0.0000
592 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
593 GASTROINTESTINAL DISORDER 1 0.0000
594 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
595 ADVERSE DRUG REACTION 1 0.0000
596 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
597 CARDIAC FAILURE CONGESTIVE 1 0.0000
598 ADVERSE EVENT 1 0.0000
599 PROSTATE CANCER 1 0.0000
600 SOMNOLENCE 2 0.0000
601 RASH 4 0.0000
602 SEIZURE 1 0.0000
603 DISEASE PROGRESSION 1 0.0000
604 MALAISE 4 0.0000
605 ASTHENIA 3 0.0000
606 NEUTROPENIA 1 0.0000
607 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
608 NAUSEA 6 0.0000
609 PRODUCT QUALITY ISSUE 1 0.0000
610 CONFUSIONAL STATE 1 0.0000
611 NASOPHARYNGITIS 1 0.0000
612 PRODUCT USE ISSUE 1 0.0000
613 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
614 INCORRECT DOSE ADMINISTERED 1 0.0000
615 BLOOD GLUCOSE INCREASED 1 0.0000
616 DRUG HYPERSENSITIVITY 1 0.0000
617 CONSTIPATION 1 0.0000
618 ERYTHEMA 1 0.0000
619 DIARRHOEA 3 0.0000
620 HEADACHE 3 0.0000
621 ANXIETY 1 0.0000
622 ARTHRALGIA 1 0.0000
623 DIZZINESS 1 0.0000
624 PAIN 1 0.0000
625 FATIGUE 1 0.0000